Literature DB >> 3038324

Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion.

B R Lucchesi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038324

Source DB:  PubMed          Journal:  Cardiovasc Clin        ISSN: 0069-0384


× No keyword cloud information.
  6 in total

Review 1.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 2.  The role of beta-receptor and calcium-entry-blocking agents in acute myocardial infarction in the thrombolytic era: can the results of thrombolytic reperfusion be enhanced?

Authors:  C J Lavie; J G Murphy; B J Gersh
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

3.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

4.  Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules.

Authors:  T Yamazaki; Y Seko; T Tamatani; M Miyasaka; H Yagita; K Okumura; R Nagai; Y Yazaki
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury.

Authors:  K Ranjadayalan; V Umachandran; S W Davies; D Syndercombe-Court; C N Gutteridge; A D Timmis
Journal:  Br Heart J       Date:  1991-07

6.  Effects of thyroid hormone analogue and a leukotrienes pathway-blocker on renal ischemia/reperfusion injury in mice.

Authors:  Najah R Hadi; Fadhil G Al-amran; Ayad A Hussein
Journal:  BMC Nephrol       Date:  2011-12-23       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.